Conditions We Treat
Allergy and Immunology
Allergic Asthma (Omalizumab/Xolair, Mepolizumab/Nucala, Benralizumab/Fasenra): Asthma triggered by allergens, causing chronic airway inflammation and constriction.
Primary Immunodeficiency (IVIG): Weakened immune system, leading to increased susceptibility to infections.
Chronic Urticaria (Omalizumab/Xolair): Persistent hives due to immune system dysfunction.
Hereditary Angioedema (C1 Esterase Inhibitors, Ecallantide, Icatibant): Recurrent episodes of swelling in various body parts due to genetic deficiency.
Cardiology
Atherosclerotic Cardiovascular Disease (Alirocumab/Praluent, Evolocumab/Repatha): Narrowing and hardening of arteries due to plaque buildup.
Congestive Heart Failure (Nesiritide/Natrecor): Inability of the heart to pump blood effectively, leading to fluid buildup.
Pulmonary Hypertension (Epoprostenol/Flolan, Treprostinil/Remodulin, Sildenafil/Revatio): High blood pressure in the arteries of the lungs.
Hyperlipidemia (Alirocumab/Praluent, Evolocumab/Repatha): High levels of fats (lipids) in the blood.
Dermatology
Psoriasis (Infliximab/Remicade, Ustekinumab/Stelara, Secukinumab/Cosentyx): Chronic autoimmune disease causing skin inflammation and rapid skin cell turnover.
Plaque Psoriasis (Adalimumab/Humira, Etanercept/Enbrel, Ustekinumab/Stelara, Secukinumab/Cosentyx): Common form of psoriasis characterized by raised, red patches with silvery scales.
Atopic Dermatitis (Dupilumab/Dupixent): Chronic inflammatory skin condition, also known as eczema.
Pemphigus Vulgaris (Rituximab/Rituxan): Rare autoimmune disorder causing blistering and erosions on the skin and mucous membranes.
Hidradenitis Suppurativa (Adalimumab/Humira): Chronic skin condition characterized by painful lumps under the skin.
Severe Acne (Isotretinoin/Accutane): Severe form of acne resistant to other treatments, causing deep, inflamed breakouts.
Gastroenterology
Crohn’s Disease (Infliximab/Remicade, Adalimumab/Humira, Vedolizumab/Entyvio,Ustekinumab/Stelara): Chronic inflammatory bowel disease causing inflammation in the digestive tract.
Ulcerative Colitis (Infliximab/Remicade, Adalimumab/Humira, Vedolizumab/Entyvio): Chronic inflammatory bowel disease causing ulcers in the lining of the colon and rectum.
Short Bowel Syndrome (Teduglutide/Gattex): Malabsorption disorder due to surgical removal of part of the small intestine.
Celiac Disease (in refractory cases) (IVIG): Autoimmune disorder triggered by gluten intolerance, leading to damage in the small intestine.
Eosinophilic Esophagitis (Corticosteroids): Chronic immune-mediated disorder causing inflammation in the esophagus.
Genetics
Fabry Disease (Agalsidase beta/Fabrazyme, Agalsidase alfa/Replagal): Rare genetic disorder causing lipid buildup in cells, affecting organs and tissues.
Gaucher Disease (Imiglucerase/Cerezyme, Velaglucerase alfa/Vpriv, Taliglucerasealfa/Protalix): Genetic disorder causing buildup of fatty substances in cells, affecting organs and tissues.
Hunter Syndrome (Idursulfase/Elaprase): Rare genetic disorder causing buildup of certain chemicals in cells, affecting organs and tissues.
Pompe Disease (Alglucosidase alfa/Myozyme): Genetic disorder causing buildup of glycogen in cells, affecting muscles and organs.
MPS I (Hurler Syndrome) (Laronidase/Aldurazyme): Genetic disorder causing buildup of complex molecules, affecting multiple organs.
Spinal Muscular Atrophy (Nusinersen/Spinraza, Onasemnogene abeparvovec/Zolgensma): Genetic disorder affecting motor neurons, leading to muscle weakness and atrophy.
Neurology
Autoimmune Encephalitis (IVIG, Rituximab/Rituxan): Rare autoimmune condition causing inflammation of the brain.
Chronic Migraines (Erenumab/Aimovig, Fremanezumab/Ajovy, Galcanezumab/Emgality): Recurrent headaches lasting hours to days, often accompanied by nausea and sensitivity to light and sound.
Myasthenia Gravis (IVIG, Plasmapheresis, Eculizumab/Soliris): Autoimmune neuromuscular disorder causing muscle weakness and fatigue.
Multiple Sclerosis (Ocrelizumab/Ocrevus, Natalizumab/Tysabri, Alemtuzumab/Lemtrada): Chronic autoimmune disease affecting the central nervous system, causing inflammation and nerve damage.
Guillain-Barré Syndrome (IVIG, Plasmapheresis): Rare autoimmune disorder affecting the peripheral nervous system, causing muscle weakness and paralysis.
Neuromyelitis Optica (Eculizumab/Soliris, Rituximab/Rituxan): Autoimmune disorder affecting the optic nerves and spinal cord, causing inflammation and damage.
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (IVIG, Plasmapheresis): Autoimmune disorder affecting the peripheral nerves, causing weakness and sensory changes.
Amyotrophic Lateral Sclerosis (ALS) (Edaravone/Radicava): Progressive neurodegenerative disease affecting nerve cells in the brain and spinal cord, causing muscle weakness and eventual paralysis.
Ophthalmology
Thyroid Eye Disease (Teprotumumab/Tepezza): Autoimmune condition causing inflammation and swelling of the muscles and tissues around the eyes.
Wet Age-Related Macular Degeneration (Ranibizumab/Lucentis, Aflibercept/Eylea,Bevacizumab/Avastin): Progressive eye disease affecting central vision due to abnormal blood vessel growth.
Uveitis (Adalimumab/Humira, Infliximab/Remicade): Inflammation of the uvea, the middle layer of the eye.
Diabetic Macular Edema (Ranibizumab/Lucentis, Aflibercept/Eylea): Swelling in the retina due to diabetes-related fluid buildup.
Retinal Vein Occlusion (Ranibizumab/Lucentis, Aflibercept/Eylea): Blockage of veins in the retina, leading to vision loss.
Orthopedics
Osteoporosis (Zoledronic acid/Reclast, Denosumab/Prolia, Teriparatide/Forteo): Bone disease characterized by decreased bone density and increased fracture risk.
Severe Osteoarthritis (Hyaluronic Acid Injections): Degenerative joint disease causing joint pain and stiffness.
Paget’s Disease of Bone (Zoledronic acid/Reclast): Chronic bone disorder causing abnormal bone growth and weakened bones.
Bone Metastases (Denosumab/Xgeva, Zoledronic acid/Reclast): Cancer that has spread to the bones from another part of the body.
Rheumatology
Ankylosing Spondylitis (Infliximab/Remicade, Adalimumab/Humira, Secukinumab/Cosentyx): Inflammatory arthritis affecting the spine and large joints.
Gout (Pegloticase/Krystexxa): Inflammatory arthritis caused by uric acid crystal deposits in the joints.
Rheumatoid Arthritis (Infliximab/Remicade, Adalimumab/Humira, Tocilizumab/Actemra, Rituximab/Rituxan): Chronic inflammatory disorder affecting joints and other tissues.
Systemic Lupus Erythematosus (SLE) (Belimumab/Benlysta, Rituximab/Rituxan): Autoimmune disease causing inflammation and damage in multiple organs and tissues.
Psoriatic Arthritis (Infliximab/Remicade, Adalimumab/Humira, Ustekinumab/Stelara): Inflammatory arthritis affecting people with psoriasis.
Polymyositis (IVIG): Rare autoimmune disease causing muscle inflammation and weakness.
Vasculitis (Rituximab/Rituxan, Cyclophosphamide): Inflammation of blood vessels, which can restrict blood flow and damage organs.
Scleroderma (Mycophenolate Mofetil/CellCept, Cyclophosphamide): Autoimmune disease causing hardening and tightening of the skin and connective tissues.
Sjögren's Syndrome (Rituximab/Rituxan): Autoimmune disorder affecting moisture-producing glands, leading to dry eyes and mouth.
Infectious Diseases
HIV/AIDS (Antiretroviral Therapy - ART): Chronic viral infection affecting the immune system.
Chronic Hepatitis B (Peginterferon alfa-2a/Pegasys): Viral infection affecting the liver.
Chronic Hepatitis C (Direct-acting Antivirals): Viral infection affecting the liver.
Severe Bacterial Infections (IV Antibiotics): Serious infections caused by bacteria.
Cytomegalovirus (Ganciclovir/Cytovene, Valganciclovir/Valcyte): Viral infection affecting multiple organs.
Osteomyelitis (IV Antibiotics): Bone infection caused by bacteria.
Sepsis (IV Antibiotics, Vasopressors): Life-threatening systemic response to infection.
Hematology
Hemophilia (Factor VIII, Factor IX, Emicizumab/Hemlibra): Genetic disorder affecting blood clotting.
Thalassemia (Deferoxamine/Desferal): Inherited blood disorder affecting hemoglobin production
Sickle Cell Disease (Hydroxyurea, L-glutamine/Endari, Crizanlizumab/Adakveo, Voxelotor/Oxbryta): Inherited blood disorder affecting red blood cells.
Iron Deficiency Anemia (IV Iron): Low red blood cell count due to insufficient iron.
Idiopathic Thrombocytopenic Purpura (ITP) (IVIG, Rituximab/Rituxan): Autoimmune disorder causing low platelet count.
Hemolytic Anemia (Eculizumab/Soliris): Anemia caused by the premature destruction of red blood cells.
Endocrinology
Severe Hypothyroidism (Levothyroxine/Synthroid): Underactive thyroid gland causing low thyroid hormone levels.
Adrenal Insufficiency (Hydrocortisone, Fludrocortisone/Florinef): Insufficient adrenal hormone production.
Diabetes Mellitus (complications) (Insulin, GLP-1 agonists): Chronic condition affecting blood sugar regulation.
Hypoparathyroidism (Parathyroid Hormone/Natpara): Parathyroid gland dysfunction causing low calcium levels.
Hyperparathyroidism (Cinacalcet/Sensipar): Parathyroid gland dysfunction causing high calcium levels.
Oncology
Various Cancers (for chemotherapy) (Cisplatin, Doxorubicin, Paclitaxel, etc.): Treatment of various types of cancer.
Lymphoma (Rituximab/Rituxan, Brentuximab vedotin/Adcetris): Cancer of the lymphatic system.
Leukemia (Blincyto, Imatinib/Gleevec, Dasatinib/Sprycel): Cancer of the blood and bone marrow.
Multiple Myeloma (Daratumumab/Darzalex, Bortezomib/Velcade): Cancer of plasma cells in the bone marrow.
Solid Tumors (Pembrolizumab/Keytruda, Nivolumab/Opdivo): Cancer affecting solid organs and tissues.
Bone Marrow Transplant Support (IVIG, G-CSF): Supportive care for patients undergoing bone marrow transplant.
Nephrology
Anemia of Chronic Kidney Disease (Erythropoiesis-Stimulating Agents): Low red blood cell count due to kidney dysfunction.
Hyperkalemia (Sodium Polystyrene Sulfonate/Kayexalate): High potassium levels in the blood.
Acute Kidney Injury (Continuous Renal Replacement Therapy - CRRT): Sudden loss of kidney function.
Renal Osteodystrophy (IV Vitamin D, Phosphate Binders): Bone disease due to kidney failure.
Solid Tumors (Pembrolizumab/Keytruda, Nivolumab/Opdivo): Cancer affecting solid organs and tissues.
Bone Marrow Transplant Support (IVIG, G-CSF): Supportive care for patients undergoing bone marrow transplant.
Pulmonology
Pulmonary Fibrosis (Nintedanib/Ofev, Pirfenidone/Esbriet): Lung disease causing scarring and stiffness of lung tissue.
Severe COPD (Roflumilast/Daliresp): Chronic obstructive pulmonary disease causing airflow obstruction.
Cystic Fibrosis (Ivacaftor/Kalydeco, Lumacaftor/Ivacaftor/Orkambi, Elexacaftor/Tezacaftor/Ivacaftor/Trikafta): Genetic disorder affecting the lungs and digestive system.
Pulmonary Arterial Hypertension (Epoprostenol/Flolan, Treprostinil/Remodulin): High blood pressure in the arteries of the lungs.
Autoimmune Disorders
Systemic Sclerosis (Cyclophosphamide/Cytoxan, Mycophenolate Mofetil/CellCept): Autoimmune disease causing fibrosis and thickening of skin and internal organs.
Dermatomyositis (IVIG, Rituximab/Rituxan): Rare autoimmune disease causing muscle weakness and skin rash.
Mixed Connective Tissue Disease (IVIG, Rituximab/Rituxan): Autoimmune disorder with features overlapping multiple connective tissue diseases.
Metabolic Disorders
Hyperammonemia (Sodium Phenylbutyrate/Buphenyl, Sodium Benzoate): Condition with high levels of ammonia in the blood.
Ornithine Transcarbamylase Deficiency (Sodium Phenylbutyrate/Buphenyl): Genetic disorder affecting the breakdown of ammonia in the body.
Pain Management
Chronic Pain Syndromes (Lidocaine Infusions, Ketamine): Persistent pain conditions requiring specialized treatment.
Reflex Sympathetic Dystrophy (Complex Regional Pain Syndrome) (IVIG, Bisphosphonates): Chronic pain condition affecting limbs after injury.
Fibromyalgia (Low-dose Ketamine): Chronic pain syndrome characterized by widespread muscle pain and tenderness.
Other Conditions ?
Severe Dehydration (IV Fluids): Life-threatening loss of fluids and electrolytes.
Malnutrition (Total Parenteral Nutrition - TPN): Severe lack of proper nutrition, requiring intravenous feeding.
Chronic Fatigue Syndrome (IVIG, Antiviral Therapy): Persistent fatigue not relieved by rest, possibly related to viral infections.
Post-COVID-19 Syndrome (Long COVID) (IVIG, Steroids): Persistent symptoms following recovery from COVID-19, requiring supportive care.
